Autocatalytically fragmented light chain of botulinum A neurotoxin is enzymatically active

被引:22
作者
Ahmed, SA
McPhie, P
Smith, LA
机构
[1] USA, Med Res Inst Infect Dis, Dept Immunol & Mol Biol, Ft Detrick, MD 21702 USA
[2] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi030062c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The zinc-endopeptidase light chain of botulinum A neurotoxin undergoes autocatalytic fragmentation that is accelerated by the presence of the metal cofactor, zinc [Ahmed, S. A. et al. (2001) J. Protein Chem. 20, 221-231]. We show in this paper that >95% fragmented light chain obtained in the absence of added zinc retained 100% of its original catalytic activity against a SNAP-25-derived synthetic peptide substrate. In the presence of zinc chloride, when >95% of the light chain had undergone autocatalytic fragmentation, the preparation retained 35% of its original catalytic activity. On the other hand, in the presence of glycerol, the light chain did not display autocatalysis and retained 100% of the original activity. These results suggest that the activity loss by incubation with zinc was not a direct consequence of autocatalysis and that the environment of the active site was not affected significantly by the fragmentation. The optimum pH 4.2-4.6 for autocatalysis was different than that (pH 7.3) for intrinsic catalytic activity. Inhibition of autocatalysis at low pH by a competitive inhibitor of catalytic activity rules out the presence of a contaminating protease but suggests a rate-limiting step of low pH-induced conformational change suitable for autocatalysis. Our results of LC concentration dependence of the fragmentation reaction indicate that the autocatalysis occurs by both intramolecular and intermolecular mechanisms.
引用
收藏
页码:12539 / 12549
页数:11
相关论文
共 51 条
[11]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438
[12]   A correlation between differential structural features and the degree of endopeptidase activity of type A botulinum neurotoxin in aqueous solution [J].
Cai, SW ;
Singh, BR .
BIOCHEMISTRY, 2001, 40 (15) :4693-4702
[13]   C-BOTULINUM NEUROTOXIN TYPE-A AND TYPE-E - ISOLATED LIGHT CHAIN BREAKS DOWN INTO 2 FRAGMENTS - COMPARISON OF THEIR AMINO-ACID-SEQUENCES WITH TETANUS NEUROTOXIN [J].
DASGUPTA, BR ;
FOLEY, J .
BIOCHIMIE, 1989, 71 (11-12) :1193-1200
[14]  
Deloye Florence, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P433
[15]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[16]   Tyrosine phosphorylation modulates the activity of clostridial neurotoxins [J].
FerrerMontiel, AV ;
Canaves, JM ;
DasGupta, BR ;
Wilson, MC ;
Montal, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18322-18325
[17]   Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release [J].
Foran, P ;
Lawrence, GW ;
Shone, CC ;
Foster, KA ;
Dolly, JO .
BIOCHEMISTRY, 1996, 35 (08) :2630-2636
[18]   Spectroscopic analysis of low pH and lipid-induced structural changes in type A botulinum neurotoxin relevant to membrane channel formation and translocation [J].
Fu, FN ;
Busath, DD ;
Singh, BR .
BIOPHYSICAL CHEMISTRY, 2002, 99 (01) :17-29
[19]  
GROVE A, 1992, METHOD ENZYMOL, V207, P510
[20]   Persistence of botulinum neurotoxin action in cultured spinal cord cells [J].
Keller, JE ;
Neale, EA ;
Oyler, G ;
Adler, M .
FEBS LETTERS, 1999, 456 (01) :137-142